| Antibody-recruiting molecules: an emerging paradigm for engaging immune function in treating human disease PJ McEnaney, CG Parker, AX Zhang, DA Spiegel ACS chemical biology 7 (7), 1139-1151, 2012 | 146 | 2012 |
| DNA-encoded solid-phase synthesis: encoding language design and complex oligomer library synthesis AB MacConnell, PJ McEnaney, VJ Cavett, BM Paegel ACS Combinatorial Science 17 (9), 518-534, 2015 | 137 | 2015 |
| A Biosynthetic Strategy for Re-engineering the Staphylococcus aureus Cell Wall with Non-native Small Molecules JW Nelson, AG Chamessian, PJ McEnaney, RP Murelli, BI Kazmiercak, ... ACS chemical biology 5 (12), 1147-1155, 2010 | 78 | 2010 |
| High-throughput Identification of DNA-Encoded IgG Ligands that Distinguish Active and Latent Mycobacterium tuberculosis Infections KR Mendes, ML Malone, JM Ndungu, I Suponitsky-Kroyter, VJ Cavett, ... ACS chemical biology 12 (1), 234-243, 2017 | 58 | 2017 |
| Chemically synthesized molecules with the targeting and effector functions of antibodies PJ McEnaney, KJ Fitzgerald, AX Zhang, EF Douglass Jr, W Shan, A Balog, ... Journal of the American Chemical Society 136 (52), 18034-18043, 2014 | 56 | 2014 |
| Reprogramming urokinase into an antibody-recruiting anticancer agent CE Jakobsche, PJ McEnaney, AX Zhang, DA Spiegel ACS chemical biology 7 (2), 316-321, 2012 | 45 | 2012 |
| Towards vast libraries of scaffold-diverse, conformationally constrained oligomers T Kodadek, PJ McEnaney Chemical communications 52 (36), 6038-6059, 2016 | 38 | 2016 |
| Screening one bead one compound libraries against serum using a flow cytometer: Determination of the minimum antibody concentration required for ligand discovery O Erharuyi, S Simanski, PJ McEnaney, T Kodadek Bioorganic & medicinal chemistry letters 28 (16), 2773-2778, 2018 | 23 | 2018 |
| High affinity binding of conformationally constrained synthetic oligomers to an antigen-specific antibody: Discovery of a diagnostically useful synthetic ligand for murine Type … TM Doran, Y Gao, S Simanski, P McEnaney, T Kodadek Bioorganic & medicinal chemistry letters 25 (21), 4910-4917, 2015 | 13 | 2015 |
| Antibody-recruiting small molecules: Synthetic constructs as immunotherapeutics PJ McEnaney, CG Parker, AX Zhang Annual Reports in Medicinal Chemistry 50, 481-518, 2017 | 8 | 2017 |
| Structural characterization of a peptoid-inspired conformationally constrained oligomer (PICCO) bound to streptavidin P McEnaney, M Balzarini, H Park, T Kodadek Chemical Communications 56 (72), 10560-10563, 2020 | 5 | 2020 |
| Synthetic antibody mimetic compounds (SYAMS) targeting cancer, especially prostate cancer DA Spiegel, P McEnaney, K Fitzgerald US Patent 10,117,943, 2018 | 5 | 2018 |
| Reliable diagnosis of murine type 1 diabetes using a panel of autoantigens and “antigen surrogates” mounted onto a liquid array TM Doran, J Morimoto, S Simanski, PJ McEnaney, T Kodadek Molecular bioSystems 11 (11), 3156-3163, 2015 | 5 | 2015 |
| New Paradigm, New Approaches: Restructuring Geospatial Information Education and Training in a Traditional Research University Setting T Lillesand, T Olsen, J Gage, P McENANEY International Archives of Photogrammetry and Remote Sensing 33 (B6; PART 6 …, 2000 | 4 | 2000 |
| AX Zhang in Annual Reports in Medicinal Chemistry PJ McEnaney, CG Parker Elsevier, Amsterdam, 2017 | 2 | 2017 |
| Methods and systems for processing or analyzing oligonucleotide encoded molecules RE Watts, D Kanichar, PJ Mcenaney US Patent App. 17/438,900, 2022 | 1 | 2022 |
| Encoded Solid Phase Compound Library with Polynucleotide Based Barcoding BM Paegel, AB MacConnell, T Kodadek, PJ McEnaney US Patent App. 16/349,097, 2020 | 1 | 2020 |
| Synthetic Immunology PJ Mcenaney, DA Spiegel Biotherapeutics: Recent Developments Using Chemical and Molecular Biology, 1, 2013 | 1 | 2013 |
| Identification and characterization of a nonbiological small-molecular mimic of a Zika virus conformational neutralizing epitope PMS Castanha, PJ McEnaney, Y Park, A Bouwer, EJF Chaves, RD Lins, ... Proceedings of the National Academy of Sciences 121 (21), e2312755121, 2024 | | 2024 |
| Synthetic antibody mimetic compounds (syams) targeting cancer, especially prostate cancer DA Spiegel, P McEnaney, K Fitzgerald US Patent App. 17/122,319, 2022 | | 2022 |
Thomas KodadekThe Scripps Research InstituteVerified email at scripps.edu
